These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 26564470)

  • 1. Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease.
    Deas E; Cremades N; Angelova PR; Ludtmann MH; Yao Z; Chen S; Horrocks MH; Banushi B; Little D; Devine MJ; Gissen P; Klenerman D; Dobson CM; Wood NW; Gandhi S; Abramov AY
    Antioxid Redox Signal; 2016 Mar; 24(7):376-91. PubMed ID: 26564470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease.
    Ludtmann MHR; Angelova PR; Horrocks MH; Choi ML; Rodrigues M; Baev AY; Berezhnov AV; Yao Z; Little D; Banushi B; Al-Menhali AS; Ranasinghe RT; Whiten DR; Yapom R; Dolt KS; Devine MJ; Gissen P; Kunath T; Jaganjac M; Pavlov EV; Klenerman D; Abramov AY; Gandhi S
    Nat Commun; 2018 Jun; 9(1):2293. PubMed ID: 29895861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca2+ is a key factor in α-synuclein-induced neurotoxicity.
    Angelova PR; Ludtmann MH; Horrocks MH; Negoda A; Cremades N; Klenerman D; Dobson CM; Wood NW; Pavlov EV; Gandhi S; Abramov AY
    J Cell Sci; 2016 May; 129(9):1792-801. PubMed ID: 26989132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC.
    Palazzi L; Fongaro B; Leri M; Acquasaliente L; Stefani M; Bucciantini M; Polverino de Laureto P
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
    Coskuner-Weber O; Uversky VN
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus.
    Devine MJ; Ryten M; Vodicka P; Thomson AJ; Burdon T; Houlden H; Cavaleri F; Nagano M; Drummond NJ; Taanman JW; Schapira AH; Gwinn K; Hardy J; Lewis PA; Kunath T
    Nat Commun; 2011 Aug; 2():440. PubMed ID: 21863007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
    Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA
    J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alpha-synuclein post-translational modifications on metal binding.
    González N; Arcos-López T; König A; Quintanar L; Menacho Márquez M; Outeiro TF; Fernández CO
    J Neurochem; 2019 Sep; 150(5):507-521. PubMed ID: 31099098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A glimpse into the structural properties of α-synuclein oligomers.
    Santos J; Pallarès I; Ventura S
    Biofactors; 2024; 50(3):439-449. PubMed ID: 38063360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular α-synuclein transfer.
    Musgrove RE; Helwig M; Bae EJ; Aboutalebi H; Lee SJ; Ulusoy A; Di Monte DA
    J Clin Invest; 2019 Jun; 129(9):3738-3753. PubMed ID: 31194700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases.
    Forloni G; Artuso V; La Vitola P; Balducci C
    Mov Disord; 2016 Jun; 31(6):771-81. PubMed ID: 27030592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.
    Rockenstein E; Nuber S; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Trejo-Morales M; Gerez J; Picotti P; Jensen PH; Campioni S; Riek R; Winkler J; Gage FH; Winner B; Masliah E
    Brain; 2014 May; 137(Pt 5):1496-513. PubMed ID: 24662516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson's Disease Etiopathology.
    Wilkaniec A; Lenkiewicz AM; Czapski GA; Jęśko HM; Hilgier W; Brodzik R; Gąssowska-Dobrowolska M; Culmsee C; Adamczyk A
    Mol Neurobiol; 2019 Jan; 56(1):125-140. PubMed ID: 29681024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells.
    Oliveira LM; Falomir-Lockhart LJ; Botelho MG; Lin KH; Wales P; Koch JC; Gerhardt E; Taschenberger H; Outeiro TF; Lingor P; Schüle B; Arndt-Jovin DJ; Jovin TM
    Cell Death Dis; 2015 Nov; 6(11):e1994. PubMed ID: 26610207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
    Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
    J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
    Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
    PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells.
    Cascella R; Chen SW; Bigi A; Camino JD; Xu CK; Dobson CM; Chiti F; Cremades N; Cecchi C
    Nat Commun; 2021 Mar; 12(1):1814. PubMed ID: 33753734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons.
    Colla E; Panattoni G; Ricci A; Rizzi C; Rota L; Carucci N; Valvano V; Gobbo F; Capsoni S; Lee MK; Cattaneo A
    Neurobiol Dis; 2018 Mar; 111():36-47. PubMed ID: 29246724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid aggregates of the deubiquitinase OTUB1 are neurotoxic, suggesting that they contribute to the development of Parkinson's disease.
    Kumari R; Kumar R; Kumar S; Singh AK; Hanpude P; Jangir D; Maiti TK
    J Biol Chem; 2020 Mar; 295(11):3466-3484. PubMed ID: 32005664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.